Overview
- The singer and former French first lady said on Instagram on December 20, 2025, that she has finished a five‑year adjuvant regimen started after a late‑2019 diagnosis.
- She outlined a treatment path of surgery followed by radiotherapy and hormonotherapy.
- She acknowledged difficult side effects from hormonotherapy but credited it with helping to reduce relapse risk in the years after diagnosis.
- She thanked her medical team for its competence and humanity and encouraged women to get checked every year if possible.
- Coverage adds that in hormone‑dependent metastatic cases, estrogen‑receptor mutations appear in about 40% of patients, prompting early blood‑based detection and combination therapy with cell‑cycle inhibitors to counter resistance.